Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis B Virus - Chronic Active”

89 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 89 results

Testing effectiveness (Phase 2)Study completedNCT02981602
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection

Who this might be right for
Hepatitis BChronic Hepatitis B Atypical
GlaxoSmithKline 31
Early research (Phase 1)Looking for participantsNCT07610772
What this trial is testing

Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection

Who this might be right for
Hepatitis D, ChronicHepatitis B Chronic Infection
Aarhus University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT03491553
What this trial is testing

Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 48
Testing effectiveness (Phase 2)WithdrawnNCT04046107
What this trial is testing

Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

Who this might be right for
Hepatitis B Virus
National Institute of Allergy and Infectious Diseases (NIAID)
Very early researchUnknownNCT03113058
What this trial is testing

"Treatment of Active HBV With γδT Cells" Clinical Trial Protocol

Who this might be right for
Adoptive Treatment for Hepatitis B With γδT Cells
Jinan University Guangzhou 60
Post-approval studies (Phase 4)Study completedNCT05286346
What this trial is testing

Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis b
Samjin Pharmaceutical Co., Ltd. 113
Early research (Phase 1)Study completedNCT02428400
What this trial is testing

Safety and Tolerability of TG1050: A Dose-finding Study

Who this might be right for
Chronic Hepatitis B
Transgene 48
Post-approval studies (Phase 4)Study completedNCT05957380
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B
Dong-A ST Co., Ltd. 120
Post-approval studies (Phase 4)Study completedNCT05282407
What this trial is testing

A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Samjin Pharmaceutical Co., Ltd. 118
Early research (Phase 1)Looking for participantsNCT06680232
What this trial is testing

Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B

Who this might be right for
HEPATITIS B CHRONIC
Precision BioSciences, Inc. 45
Post-approval studies (Phase 4)Study completedNCT06000657
What this trial is testing

Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir

Who this might be right for
Hepatitis B, Chronic
Daewoong Pharmaceutical Co. LTD. 196
Early research (Phase 1)Ended earlyNCT02797522
What this trial is testing

ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B
Arrowhead Pharmaceuticals 47
Post-approval studies (Phase 4)Study completedNCT00393484
What this trial is testing

A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb 122
Testing effectiveness (Phase 2)Study completedNCT04535544
What this trial is testing

JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

Who this might be right for
Hepatitis D, Chronic
Janssen Research & Development, LLC 52
Post-approval studies (Phase 4)Not Yet RecruitingNCT07345611
What this trial is testing

Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B

Who this might be right for
Hepatitis B Virus InfectionChildrenChronic Hepatitis B
Qing-Lei Zeng 60
Testing effectiveness (Phase 2)Ended earlyNCT04536532
What this trial is testing

Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study

Who this might be right for
Hepatitis B, Chronic
Sunshine Lake Pharma Co., Ltd. 52
Large-scale testing (Phase 3)Ended earlyNCT00313287
What this trial is testing

Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV

Who this might be right for
Hepatitis B
Bukwang Pharmaceutical 180
Large-scale testing (Phase 3)UnknownNCT03759782
What this trial is testing

Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity

Who this might be right for
Hepatitis B, Chronic
Ottawa Hospital Research Institute 24
Testing effectiveness (Phase 2)Study completedNCT04412863
What this trial is testing

Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B
Vir Biotechnology, Inc. 84
Post-approval studies (Phase 4)Study completedNCT00641082
What this trial is testing

Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function

Who this might be right for
HBeAg(-) Chronic Hepatitis B With Compensated Liver Function
Bukwang Pharmaceutical 43
Next Page